Share on StockTwits

Shire PLC (NASDAQ:SHPGY) has been given an average recommendation of “Buy” by the twelve ratings firms that are covering the stock, AnalystRatings.NET reports. Three equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $260.00.

A number of research firms have recently commented on SHPGY. Analysts at Buckingham Research downgraded shares of Shire PLC to a “neutral” rating in a research note on Tuesday, July 22nd. Separately, analysts at Leerink Swann downgraded shares of Shire PLC to a “market perform” rating in a research note on Monday, July 21st. Finally, analysts at Jefferies Group reiterated a “buy” rating on shares of Shire PLC in a research note on Monday, July 21st.

Shire plc (NASDAQ:SHPGY) is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.